FY27-28 Adult Flu Vaccines
Closed Solicitation Posted
- Solicitation number
- 75D30126R73517
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia 30329, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention seeks to establish one or more Indefinite Delivery/Indefinite Quantity contracts for the purchase of FDA-approved standard commercial adult influenza vaccines, with proposals due September 16, 2026 at 1:00 PM EST and questions due September 9, 2026 at 1:00 PM EST. This is a Women-Owned Small Business set-aside procurement.
The combined aggregate maximum ceiling value across all awards is $400 million. Contract performance runs from December 31, 2026 through February 28, 2028. The CDC intends to award contracts to all qualifying offerors meeting solicitation requirements. Place of performance is Atlanta, Georgia, with delivery F.O.B. Destination to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky.
Vaccines will support the Section 317(j) immunization program and be distributed to the fifty state health departments, several large city programs, and U.S. Territories for adult populations at greatest risk for under-vaccination. Offerors must propose vaccines with pricing not to exceed the manufacturer's Provisional and Permanent Federal Ceiling Price as established by the Department of Veterans Affairs, with Federal Excise Tax at $0.75 per dose included. Minimum order size is 100 doses per vaccine; maximum is 6 million doses per contract line item. Vaccines must have shelf life expiring no earlier than June 30, 2028.
Offerors must demonstrate ability to interface with the CDC's Vaccine Tracking System for electronic ordering and comply with Current Good Manufacturing Practice Regulations. All offerors except small businesses must submit an acceptable subcontracting plan by the proposal deadline. Contractors using artificial intelligence in contract performance must submit an approved AI Compliance and Risk Management Plan. The CDC will publicly disclose vaccine pricing information, including per-dose pricing, product names, NDC numbers, and contract numbers; offerors authorize such disclosure by submission. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing.
Notice text
The Centers for Disease Control and Prevention (CDC) awards one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines. The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease. The 317 program as established under Section 317(j) of the Public Health Service Act, works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease’s (NCIRD’s) immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.
Files
| File | Type | Posted |
|---|---|---|
| A19 75D30126R73517 0001 FY27-28 Adult Flu Sol..docx | DOCX document | |
| A19 - 75D30126R73517 0001 - 1449 Solicitation Cover Page 2021 version.pdf | ||
| A19 D-1 ADR.docx | DOCX document | |
| A19 D-2 List of Products.docx | DOCX document | |
| A19 - 75D30126R73517 - 1449 Solicitation Cover Page 2021 version.pdf | ||
| A19 D-3 AI Use Compliance and Risk Management Plan.docx | DOCX document | |
| A19 75D30126R73517 FY27-28 Adult Flu Sol..docx | DOCX document | |
| A19 D-4 Public Disclosure and Publication of Vaccine Pricing.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity